Related Experiment Video
Updated: Aug 13, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Relationship of glymphatic dysfunction and frontothalamic structure with cognitive impairment in attention deficit
Manxue Zhang1,2, Bohua Li3, Sixun Li1,4
1Laboratory of Child and Adolescent Psychiatry, Mental Health Center and Psychiatric Laboratory, West China Hospital, Sichuan University, 37 Guoxue Lane, Wuhou District, Chengdu, Sichuan 610041, China.
None:
Cognitive deficits constitute a core feature of attention deficit hyperactivity disorder (ADHD), yet their underlying neurobiological mechanisms remain incompletely understood. This study investigates the tripartite relationship among glymphatic function, gray matter volume (GMV), and cognitive deficits in pediatric ADHD. We enrolled 159 children with ADHD and 163 typically developing controls. All participants underwent cognitive assessments and multimodal magnetic resonance imaging (MRI). We analyzed group differences in cognitive performance, GMV, and glymphatic function. Exploratory mediation analyses using a regression-based approach (PROCESS) were used to examine the relationships between these variables. Children with ADHD showed significant impairment in sustained attention and emotional regulation (P < 0.001). The ADHD group exhibited reduced glymphatic function, as indicated by a lower along the Perivascular Space (ALPS) index (P < 0.001). GMV abnormalities in ADHD spatially overlapped with ALPS-anchored regions in the parahippocampal-thalamo-frontal circuits. Critically, exploratory mediation analysis provided preliminary, hypothesis-generating evidence that the association between reduced GMV in prefrontal regions (left medial prefrontal cortex and medial superior frontal gyrus) and cognitive deficits may be mediated by glymphatic dysfunction (P < 0.05). Our findings establish glymphatic dysfunction as a feature of pediatric ADHD that co-occurs with fronto-thalamic abnormalities, nominating the glymphatic system as a potential therapeutic target for cognitive comorbidities in ADHD.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Dementia l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction

